AU2003232217A1 - Use of agmatine for topical application - Google Patents

Use of agmatine for topical application

Info

Publication number
AU2003232217A1
AU2003232217A1 AU2003232217A AU2003232217A AU2003232217A1 AU 2003232217 A1 AU2003232217 A1 AU 2003232217A1 AU 2003232217 A AU2003232217 A AU 2003232217A AU 2003232217 A AU2003232217 A AU 2003232217A AU 2003232217 A1 AU2003232217 A1 AU 2003232217A1
Authority
AU
Australia
Prior art keywords
agmatine
topical application
topical
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003232217A
Inventor
Johannes Wohlrab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003232217A1 publication Critical patent/AU2003232217A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
AU2003232217A 2002-05-02 2003-04-29 Use of agmatine for topical application Abandoned AU2003232217A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10219644.3 2002-05-02
DE10219644A DE10219644A1 (en) 2002-05-02 2002-05-02 Use of agmatine for topical application
PCT/EP2003/004444 WO2003092668A1 (en) 2002-05-02 2003-04-29 Use of agmatine for topical application

Publications (1)

Publication Number Publication Date
AU2003232217A1 true AU2003232217A1 (en) 2003-11-17

Family

ID=29265002

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232217A Abandoned AU2003232217A1 (en) 2002-05-02 2003-04-29 Use of agmatine for topical application

Country Status (3)

Country Link
AU (1) AU2003232217A1 (en)
DE (1) DE10219644A1 (en)
WO (1) WO2003092668A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050003024A1 (en) * 2003-03-04 2005-01-06 The Procter & Gamble Company Regulation of mammalian hair growth
WO2008113364A2 (en) * 2007-03-20 2008-09-25 Recepticon Aps Amino derivatives to prevent nephrotoxicity and cancer
US11622949B1 (en) 2022-08-04 2023-04-11 Gad M. Gilad Agmatine compositions for treatment of osteoarthritis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507321A (en) * 1982-02-17 1985-03-26 The Research Foundation Of State University Of New York Epithelial cell growth regulating composition containing polyamines and a method of using same
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
US5677349A (en) * 1995-04-27 1997-10-14 Gilad; Gad M. Agmatine for the treatment of neurotrauma and neurodegenerative diseases
US5939078A (en) * 1995-11-20 1999-08-17 Kao Corporation Wrinkle-care product
FR2753098B1 (en) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE NO SYNTHASE INHIBITOR AND AT LEAST ONE TRAP FOR REACTIVE OXYGEN FORMS
MXPA00009705A (en) * 1998-04-03 2003-07-14 Univ Manitoba The use of polyamines in the treatment of dermatological symptoms.
US6544541B1 (en) * 1999-06-02 2003-04-08 Cardiovascular Solutions, Inc. Devices and compounds for treating arterial restenosis
US7045550B2 (en) * 2001-08-07 2006-05-16 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy

Also Published As

Publication number Publication date
WO2003092668A1 (en) 2003-11-13
DE10219644A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AU2003220935A1 (en) Benzamide derivatives
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003241882A1 (en) Applicator
AU2003261974A1 (en) Amine compounds and use thereof
AU2003254844A1 (en) Substituted amino compounds and use thereof
AU2003211093A1 (en) Inhibitors of rgs proteins
AU2003216579A1 (en) Imidazole compounds as anti-inflammatory and analgesic agents
AU2003249683A1 (en) Nf-:b inhibitors
AU2003220968A1 (en) Anti-inflammatory agent
AU2003275330A1 (en) Flexible device for topical application of pdt
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003228198A1 (en) Av-fistula bandage
AU2003289207A1 (en) Anti-inflammatory agent
AU2003258941A1 (en) Metalloproteinase inhibitors and intermediates for preparation thereof
AU2003298582A1 (en) Therapeutic guanidines
AU2003216848A1 (en) Deracemisation of amines
AU2003258239A1 (en) Clip applicator tool
AU2003232217A1 (en) Use of agmatine for topical application
AU2002952559A0 (en) New use
GB0306085D0 (en) Improved composition for topical application
AU2003207181A1 (en) Microorganism-trapping agent
AU2003264443A1 (en) Preparation for external use
AU2002951868A0 (en) Compound i
AU2003289011A1 (en) Composition for topical anesthesia
GB2392384B (en) Compositions for topical application

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase